Mckinley Capital Management LLC Biogen Inc. Transaction History

Mckinley Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $2.29 Million - $2.94 Million	-10,220 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $2.41 Million - $3.63 Million	10,220 New	10,220 $2.5 Million
Q2 2019 Aug 07, 2019	SELL	$219.29 - $241.72 $52,410 - $57,771	-239 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$216.71 - $338.96 $178,352 - $278,964	-823 Reduced 77.5%	239 $56,000
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $93,576 - $118,524	336 Added 46.28%	1,062 $320,000
Q3 2018 Nov 08, 2018	BUY	$293.51 - $383.83 $213,088 - $278,660	726 New	726 $257,000
Q2 2018 Jul 13, 2018	SELL	$257.52 - $306.91 $173,310 - $206,550	-673 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$260.13 - $367.91 $175,067 - $247,603	673 New	673 $185,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.